Pluri Inc. Derivative Asset, Fair Value, Amount Not Offset Against Collateral
Pluri Inc. (PLUR) had Derivative Asset, Fair Value, Amount Not Offset Against Collateral of $86.00 thousand as of 2013-09-30, per its 10-Q filed 2013-11-05.
Discontinued › Notes
us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral · last filed 2013-11-05
- 2013-09-30: Derivative Asset, Fair Value, Amount Not Offset Against Collateral $86.00K.
- 2013-06-30: Derivative Asset, Fair Value, Amount Not Offset Against Collateral $93.00K.
| Period end | Derivative Asset, Fair Value, Amount Not Offset Against Collateral |
|---|---|
| 2013-09-30 | $86.00K 10-Q · filed 2013-11-05 |
| 2013-06-30 | $93.00K 10-Q · filed 2013-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |